Cresco Labs Inc

Most Recent

  • Cresco Labs Bluma Wellness Cannabis Merger
    Cannabis

    To Buy or Not to Buy the Dip on Cresco Labs (CRLBF) Stock

    By Ambrish Shah
  • Jar of Cresco Labs marijuana
    Cannabis

    Cresco Labs Stock Is a Buy Due to Strong Growth Prospects

    By Ambrish Shah
  • uploads///part
    Miscellaneous

    Cresco Labs Gets Another ‘Buy’ Rating

    Yesterday, Eight Capital initiated coverage on Cresco Labs (CRLBF) with a “buy” rating.

    By Mohit Oberoi, CFA
  • uploads///acreage holdings q results
    Cannabis

    Acreage Holdings Posts Disappointing Results in Q1 2020

    Acreage Holdings’ first-quarter pro forma revenue grew 65% YoY (year-over-year) to $37.6 million. The revenue beat analysts’ estimates of $34.9 million.

    By Sushree Mohanty
  • uploads///part
    Earnings Report

    How Analysts View Cresco Labs before Its Q1 Release

    Cresco Labs (CRLBF) is slated to release its first-quarter earnings on May 29.

    By Mohit Oberoi, CFA
  • uploads///illinois cannabis sales
    Cannabis

    Illinois’ Cannabis Sales Soared in June: Which Stocks Will Benefit?

    Cannabis sales have been soaring in all of the US states that classified it as an “essential item” amid the pandemic. Illinois has seen tremendous growth.

    By Sushree Mohanty
  • uploads///cresco labs earnings
    Cannabis

    Cresco Labs’ Q1 Earnings: Dazzling Growth amid COVID-19

    Cresco Labs reported its results for the first quarter of fiscal 2020 on May 28. The stock declined 4.2% and closed at $4.8 on the OTC markets yesterday.

    By Sushree Mohanty
  • uploads///canopy growth up
    Cannabis

    Canopy Growth Might Impress Investors with Its Q4 Earnings

    Canopy Growth (NYSE:CGC)(TSE:WEED) will likely report its results for the fourth quarter of fiscal 2020 on May 29 before the market opens.

    By Sushree Mohanty
  • uploads///south dakota marijuana
    Cannabis

    Marijuana Legalization in South Dakota Lies with Voters Now

    Marijuana legalization in South Dakota could see daylight in 2020. The state passed measures to legalize both recreational and medical marijuana.

    By Sushree Mohanty
  • uploads///medmen recovery
    Cannabis

    Did MedMen’s Q3 Earnings Start a Path to Recovery?

    MedMen released its results for the third quarter of fiscal 2020 on May 27. The stock declined 4.0% and closed at $0.35 on the OTC markets.

    By Sushree Mohanty
  • uploads///cresco labs
    Cannabis

    Why Origin House’s Acquisition Is Vital for Cresco Labs

    On December 31, 2019, Origin House (OH) announced that its shareholders had approved Cresco Labs’ (CRLBF) acquisition plan.

    By Rajiv Nanjapla
  • uploads///cresco labs ohio
    Cannabis

    Cresco Labs Announces Expansion in Ohio before Q1 Earnings

    Cresco Labs (OTCMKTS:CRLBF) will likely report its financial results for the first quarter of fiscal 2020 on May 28 after the market closes.

    By Sushree Mohanty
  • uploads///curaleaf new jersey
    Cannabis

    Curaleaf Holdings Completes Curaleaf NJ’s Acquisition

    Curaleaf Holdings (OTCMKTS:CURLF) continued its expansion by completing the acquisition of Curaleaf NJ, which owns a medical license in New Jersey.

    By Rajiv Nanjapla
  • uploads///marijuana
    Cannabis

    Marijuana Legalization Still Has a Chance in Idaho

    Marijuana legalization in Idaho had to bear the brunt of the coronavirus pandemic. The lockdown forced the state to suspend its medical marijuana campaign.

    By Sushree Mohanty
  • uploads///curaleaf q earnings
    Cannabis

    Curaleaf Plans a Nationwide Expansion of ‘Select’ Brand

    Curaleaf (OTCMKTS:CURLF) acquired a “Select” brand in February 2020. The company received positive feedback in medical and adult-use markets.

    By Rajiv Nanjapla
  • uploads///green thumb store
    Cannabis

    Green Thumb Keeps Expanding Its Operations in Las Vegas

    On June 27, Green Thumb Industries (OTCMKTS:GTBIF) opened its fifth Essence brand store in Las Vegas and its 48th retail store in the US.

    By Rajiv Nanjapla
  • uploads///canopy growth acreage holdings deal
    Cannabis

    Canopy Growth Revised Its Agreement with Acreage Holdings

    Canopy Growth entered into an agreement with US-based cannabis company Acreage Holdings last year. However, the company announced some changes.

    By Sushree Mohanty
  • uploads///acreage holdings upcoming results
    Cannabis

    Could Acreage Holdings’ Q1 Earnings Boost Its Stock?

    Acreage Holdings (OTCMKTS:ACRGF) will likely report its results for the first quarter of fiscal 2020 on Friday before the market opens.

    By Sushree Mohanty
  • uploads///illinois cannabis growth
    Cannabis

    Cannabis Market in Illinois Grows, Challenges Remain

    The growth in Illinois’s cannabis market is evident from its record sales in May. The state sold adult-use cannabis worth $44.3 million in May.

    By Sushree Mohanty
  • uploads///medmen relief
    Cannabis

    MedMen’s Medical Marijuana Dispensary License Revoked in Virginia

    The Virginia Board of Pharmacy voted not to extend MedMen’s conditional license to operate a medical marijuana dispensary in Staunton, Virginia.

    By Rajiv Nanjapla
  • uploads///virgin islands marijuana legalization
    Cannabis

    U.S. Virgin Islands’ Governor Supports Marijuana Legalization

    While most businesses suffered amid COVID-19, marijuana saw a drastic rise in sales. Many states have been rethinking the benefits of marijuana legalization.

    By Sushree Mohanty
  • uploads///charlottes web abacus health
    Cannabis

    Will the Abacus Health Acquisition Benefit Charlotte’s Web?

    On June 11, Charlotte’s Web announced that it completed the acquisition of Abacus Health. The company’s performance wasn’t strong in the first quarter.

    By Sushree Mohanty
  • uploads///Curaleaf
    Cannabis

    Curaleaf Expands Select Brand Medical Products in Connecticut

    On Monday, Curaleaf Holdings announced that it will expand its Select brand products in Connecticut. The products will be available at medical dispensaries.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Illinois Reports Record Recreational Cannabis Sales in May

    Illinois sold recreational cannabis worth $44.3 million in May—the highest amount since it legalized recreational sales in January this year.

    By Rajiv Nanjapla
  • uploads///cresco labs stifel canada
    Cannabis

    Why Stifel Canada Thinks Cresco Labs Is a ‘Buy’

    Cresco Labs (OTMKTS:CRLBF) started fiscal 2020 on a good note with strong first-quarter results. The company had triple-digit revenue growth.

    By Sushree Mohanty
  • uploads///green thumb industries
    Cannabis

    Green Thumb Industries Opens Its 46th Retail Store

    On Monday, Green Thumb Industries (OTCMKTS:GTBIF) opened a Rise brand store in Chambersburg, Pennsylvania—its 46th store in the US.

    By Rajiv Nanjapla
  • uploads///Vireo Health
    Cannabis

    Vireo Health Terminates Bruce Linton as Its Executive Chairman

    On Monday, Vireo Health announced that it terminated Bruce Linton as its executive chairman immediately. He joined the company in November 2019.

    By Rajiv Nanjapla
  • uploads///marijuana new mexico primaries
    Cannabis

    Marijuana Legalization: New Mexico Voters Show Support

    In the 2020 New Mexico Democratic presidential primaries election on June 2, voters ousted most of the Senate candidates who opposed marijuana legalization.

    By Sushree Mohanty
  • uploads///cresco labs ohio approval
    Cannabis

    Cresco Labs Receives Ohio Provisional Processing License

    Cresco Labs (OTCMKTS:CRLBF) is trading 1.8% higher as of 9:44 AM ET today. The company received a provisional processing license by the state of Ohio.

    By Sushree Mohanty
  • uploads///cannabis illinois
    Cannabis

    Cannabis Market Has Good Potential in Illinois

    The cannabis market in Illinois has been growing despite the COVID-19 pandemic. Illinois legalized recreational cannabis on January 1, 2020.

    By Sushree Mohanty
  • uploads///new york marijuana again
    Cannabis

    Marijuana Legalization Attempts in New York amid Protests

    George Floyd’s death has led to mass protests in the US. Notably, social injustice was one of the main motives behind legalizing marijuana.

    By Sushree Mohanty
  • uploads///cresco labs estimates
    Cannabis

    Cresco Labs: Analysts Revise 2020 Estimates after Earnings

    Cresco Labs (OTCMKTS:CRLBF) is one of the US cannabis companies that has been consistently performing well despite the marijuana industry’s struggles.

    By Sushree Mohanty
  • uploads///medmen stores closed
    Cannabis

    MedMen Temporarily Closes Stores amid Protests

    Amid the protests following George Floyd’s death in the US, MedMen temporarily closed all of its stores. The stock fell after the news.

    By Sushree Mohanty
  • uploads///new mexico marijuana legalization
    Cannabis

    Marijuana Legalization Might Bring Economic Relief in New Mexico

    Governor Grisham thinks that marijuana is a good option to help New Mexico recover from the economic losses amid COVID-19.

    By Sushree Mohanty
  • uploads///green thumb industries good bet
    Cannabis

    Why Green Thumb Industries Is a Good Cannabis Bet

    So far in 2020, Green Thumb Industries has returned 6.0%—one of the few cannabis companies with positive returns this year.

    By Rajiv Nanjapla
  • uploads///medmen relief
    Cannabis

    Will MedMen’s Q3 2020 Earnings Be a Relief?

    MedMen Enterprises (OTCMKTS:MMNFF) is scheduled to report its financial results for the third quarter of fiscal 2020 on May 27 after the market closes.

    By Sushree Mohanty
  • uploads///Curaleaf
    Cannabis

    Curaleaf: Analysts’ Recommendations after Its Q1 Earnings

    Earlier this week, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings. The company missed analysts’ revenue expectations.

    By Rajiv Nanjapla
  • uploads///curaleaf q earnings
    Cannabis

    Why Did Curaleaf Report a Mixed Q1 Performance?

    On Monday, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings after the market closed. The company reported revenue of $96.5 million.

    By Rajiv Nanjapla
  • uploads///texas marijuana
    Cannabis

    Could Marijuana Legalization Help Texas Recover Its Losses?

    Texas has suffered huge economic losses. Many industry experts think that marijuana legalization could be a good option to revive the state’s economy.

    By Sushree Mohanty
  • uploads///cweb_
    Cannabis

    Why Curaleaf Is a ‘Buy’ before Its Q1 Earnings

    Analysts expect Curaleaf’s EBITDA to rise during the quarter. They expect the company to report an EBITDA of $15.7 million.

    By Rajiv Nanjapla
  • uploads///cweb_
    Cannabis

    Charlotte’s Web Reports Mixed Q1 Performance

    Today, Charlotte’s Web reported a mixed first-quarter performance. For the quarter ended on March 31, the company reported revenues of $21.7 million.

    By Rajiv Nanjapla
  • uploads///cannabis relief
    Cannabis

    Marijuana: Banking Access Included in Coronavirus Relief Bill

    Marijuana companies in the US have been struggling to get financial and banking access. Cannabis still isn’t legal at the federal level.

    By Sushree Mohanty
  • uploads///green thumb store
    Cannabis

    New Cannabis Store Opens before Green Thumb’s Q1 Earnings

    Green Thumb Industries (OTCMKTS:GTBIF) will likely report its results for the first quarter of fiscal 2020 on May 14 after the market closes. 

    By Sushree Mohanty
  • uploads///massachusetts cannabis aid
    Cannabis

    Massachusetts Wants to Help Cannabis Businesses amid COVID-19

    Massachusetts made medical cannabis essential amid the COVID-19 pandemic. However, recreational cannabis dispensaries had to shut down.

    By Sushree Mohanty
  • uploads///iipr earnings
    Cannabis

    IIPR Stock Falls after Reporting Weak Q1 Performance

    On May 6, Innovative Industrial Properties reported its first-quarter results after the market closed. The company posted an adjusted EPS of $0.72.

    By Rajiv Nanjapla
  • uploads///cannabis legalization nebraska
    Cannabis

    Marijuana Legalization in Nebraska Has a New Strategy

    Marijuana campaigns have struggled to gather signatures amid the coronavirus pandemic. However, there’s still some hope in Nebraska.

    By Sushree Mohanty
  • uploads///CRON_
    Cannabis

    Should You Buy IIPR before Its Q1 Earnings?

    IIPR will likely report its first-quarter earnings, which ended on March 31, after the market closes on May 6. So, should you buy the stock?

    By Rajiv Nanjapla
  • uploads///marijauna in may
    Cannabis

    Marijuana Investors: Forecast in May amid COVID-19

    We still don’t know how COVID-19 will impact marijuana companies. Their sales will likely keep rising in May if lockdowns and stay-at-home orders continue.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana Legalization Sees Daylight in Lebanon, US Still Waits

    Amid COVID-19, people rushed to stock up on marijuana. Lebanon is the first Middle East country to legalize medical marijuana amid the pandemic.

    By Sushree Mohanty
  • uploads///cresco labs surprise results
    Cannabis

    Cresco Labs’ Q4 Earnings: Pleasant Surprise amid COVID-19

    Cresco Labs reported its results for the fourth quarter of fiscal 2019 on April 27. Analysts were hopeful about the company’s fourth-quarter earnings.

    By Sushree Mohanty
  • uploads///Marijuana
    Cannabis

    Why Is There Optimism before Cresco Labs’ Q4 Earnings?

    Analysts expect Cresco Labs to report revenue of $43.7 million in the fourth quarter—YoY growth of 157.9% from $17.0 million in the fourth quarter of 2018.

    By Rajiv Nanjapla
  • uploads///cresco labs stock price
    Cannabis

    Is There More Upside to Cresco Labs’ Stock Price?

    Amid the weakness in the global financial markets due to the COVID-19 outbreak, Cresco Labs fell to a low of 2.81 Canadian dollars on March 17.

    By Rajiv Nanjapla
  • uploads///CWEB_
    Cannabis

    Analysts’ Recommendations after Charlotte’s Web’s Q4 Earnings

    Charlotte’s Web Holdings reported its fourth-quarter earnings on March 24. For the quarter, the company missed analysts’ revenue and EBITDA estimates.

    By Rajiv Nanjapla
  • uploads///curaleaf target price
    Cannabis

    Analysts Cut Curaleaf’s Target Price after Its Q4 Earnings

    Since Curaleaf reported its fourth-quarter earnings on March 24, Alliance Global Partners and Canaccord Genuity have lowered their target prices.

    By Rajiv Nanjapla
  • uploads///curaleaf earnings results
    Cannabis

    Curaleaf Reports Impressive Q4 Earnings Results

    On Tuesday, Curaleaf (OTCMKTS:CURLF) reported its fourth-quarter earnings after the market closed. The company reported revenue of $75.46 million.

    By Rajiv Nanjapla
  • uploads///curaleaf beat expectations
    Cannabis

    Will Curaleaf Beat Analysts’ Expectations in Q4?

    Curaleaf Holdings (OTCMKTS:CURLF) will report its fourth-quarter earnings after the market closes on March 24. Analysts are bullish on Curaleaf.

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    Roth Capital Initiates Coverage on IIPR with a ‘Buy’ Rating

    On March 16, Roth Capital initiated coverage on Innovative Industrial Properties (NYSE:IIPR) with a “buy” rating and a stock price of $110.

    By Rajiv Nanjapla
  • uploads///curaleaf upcoming results
    Cannabis

    Analysts Recommend a ‘Buy’ for Curaleaf before Its Q4 Earnings

    As of Thursday, nine analysts covered Curaleaf. Among the analysts, eight recommend a “buy,” while one recommends a “hold.”

    By Rajiv Nanjapla
  • uploads///IIPR cannabis sector
    Cannabis

    IIPR Looks Promising amid Struggling Cannabis Sector

    As of March 11, Innovative Industrial Properties (NYSE:IIPR) was trading at $76.96—a rise of 1.4% since the beginning of this year.

    By Rajiv Nanjapla
  • uploads///supreme cannabis analysts hold rating
    Cannabis

    What Do Analysts Recommend for Supreme Cannabis?

    Wall Street favors a “hold” rating for Supreme Cannabis. Four analysts recommend a ‘hold,’ three recommend a ‘buy,’ and one recommends a ‘sell.’

    By Rajiv Nanjapla
  • uploads///Green Growth
    Cannabis

    Charlotte’s Web Reports Improved Yield and CBD Potency

    On Wednesday, Charlotte’s Web Holdings (NYSEARCA:CWEB) announced that the audit of its 2019 hemp harvest is complete.

    By Rajiv Nanjapla
  • uploads///curaleaf bluekudu
    Cannabis

    How Will Curaleaf Benefit from Acquiring BlueKudu?

    On Monday, Curaleaf (OTCMKTS:CURLF) announced that it will acquire BlueKudu—a company that produces premium cannabis chocolates and gummies.

    By Rajiv Nanjapla
  • uploads///gw pharmaceuticals target price cut
    Cannabis

    Analysts Cut GW Pharmaceuticals’s Target Price after Q4 Earnings

    On Tuesday, GW Pharmaceuticals reported its fourth-quarter earnings. The company reported revenue of $109.1 million, which beat analysts’ expectations.

    By Rajiv Nanjapla
  • uploads///CBD_
    Cannabis

    IIPR Posts Impressive Q4 Earnings, Looks Strong in 2020

    On Wednesday, IIPR reported its fourth-quarter earnings. The company reported revenues of $17.7 million, which beat analysts’ expectations of $14.4 million.

    By Rajiv Nanjapla
  • uploads///GWPH_
    Cannabis

    Analyzing GW Pharmaceuticals’ Q4 Earnings and Outlook

    On Tuesday, GW Pharmaceuticals reported its fourth-quarter earnings after the market closed. For the quarter, the company reported revenue of $109.1 million.

    By Rajiv Nanjapla
  • uploads///green growth brands upcoming earnings
    Cannabis

    What to Expect from Green Growth Brands’ Q2 Earnings?

    Green Growth Brands will likely report its results for the second quarter of fiscal 2020 on February 24. Analysts expect the company’s revenue to rise sequentially.

    By Rajiv Nanjapla
  • uploads///APHA_
    Cannabis

    Has Cresco Labs Bottomed Out in 2020?

    As of Tuesday, Cresco Labs was trading at 6.73 Canadian dollars, which represents a fall of 24.6% since the beginning of the year.

    By Rajiv Nanjapla
  • uploads///curaleaf__
    Cannabis

    Beacon Securities Is Still Bullish on Curaleaf

    After Curaleaf completed the acquisition of the Select brand, Russell Stanley of Beacon Securities reiterated his “buy” rating.

    By Rajiv Nanjapla
  • uploads///iipr and gti
    Cannabis

    IIPR Enters a Long-Term Agreement with GTI

    Yesterday, IIPR announced that it bought a licensed cannabis processing facility in Toledo, Ohio, from Green Thumb Industries for $2.9 million.

    By Rajiv Nanjapla
  • uploads///CL_
    Cannabis

    Cresco Labs Stock Rose after Securing $100 Million Loan

    On Thursday, Cresco Labs announced that it signed an agreement for a senior secured term loan for an initial aggregate principal amount of $100 million.

    By Rajiv Nanjapla
  • uploads///CL_
    Cannabis

    Is Cresco Labs a Good Bet in January?

    Analysts expect Cresco Labs to report revenues of $45.3 million in the fourth quarter to take the total revenue for 2019 to $131.9 million.

    By Rajiv Nanjapla
  • uploads///curaleaf__
    Cannabis

    Why Beacon Securities Is Bullish on Curaleaf

    On Monday, Russell Stanley of Beacon Securities reiterated his “buy” rating for Curaleaf Holdings. He gave a target price of 25 Canadian dollars.

    By Rajiv Nanjapla
  • uploads///cweb_
    Cannabis

    Is Charlotte’s Web Still a Good Buy?

    Although 2019 was tough for Charlotte’s Web Holdings, it has made a significant recovery this year. The stock has increased by 14.8% YTD as of Monday.

    By Rajiv Nanjapla
  • uploads///GW Pharmaceuticals
    Cannabis

    GW Pharmaceuticals Provides Preliminary Sales Update

    On January 12, GW Pharmaceuticals announced its preliminary unaudited product sales report for the fourth quarter and 2019.

    By Rajiv Nanjapla
  • uploads///OGI_pic
    Cannabis

    OrganiGram’s First-Quarter Earnings: What to Expect

    Yesterday, OrganiGram stock was trading at 2.68 Canadian dollars, 23.4% lower than when the company reported its fourth-quarter earnings on November 25.

    By Rajiv Nanjapla
  • uploads///TerrAscend
    Cannabis

    TerrAscend Private Placement Oversubscribed

    TerrAscend’s recent private placement was oversubscribed due to strong investor interest. It increased the offering to about $30 million from $20 million.

    By Rajiv Nanjapla
  • uploads///cresco_
    Cannabis

    Why Beacon Securities Thinks Cresco Labs Is Cheap

    Russell Stanley of Beacon Securities is optimistic about Cresco Labs (CRLBF) in the cannabis space. He maintained the “buy” rating and target price.

    By Rajiv Nanjapla
  • uploads///can_
    Cannabis

    How Was 2020’s First Trading Day for Cannabis?

    Yesterday, Illinois debuted the sale of adult-use cannabis. Green Thumb Industries announced that it opened its first adult-use cannabis store in the state.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    Illinois Wakes Up to Legalized Recreational Cannabis

    On June 25, Illinois governor J.B. Pritzker signed a bill approving marijuana use for everyone over 21 years old. The law became effective on January 1.

    By Margaret Patrick
  • uploads///can_
    Cannabis

    Cannabis Sector Rounds Out the Week in the Green

    Yesterday, Ontario’s government announced that it was scrapping its cap on the number of private retail cannabis stores and moving toward a new system.

    By Rajiv Nanjapla
  • uploads///MedMen
    Cannabis

    Why MedMen Stock Rose More than 24% on Thursday

    The optimistic guidance and initiatives helped MedMen stock rise. On Thursday, the stock closed the day at 0.71 Canadian dollars.

    By Rajiv Nanjapla
  • uploads///Fire
    Cannabis

    Supreme Cannabis: Lower Target Price after Q1 Earnings

    Following Supreme Cannabis’s weak first-quarter performance, PI Financial and Canaccord Genuity lowered their target prices.

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    MedMen: Price Targets and Ratings after Q1 Earnings

    There have been no rating changes since MedMen reported its Q1 earnings. Six of eight analysts gave the stock a “hold” rating.

    By Rajiv Nanjapla
  • uploads///can
    Cannabis

    Cannabis Stocks Up despite Weak Equity Market

    Despite the weakness in the broader US equity market today, the cannabis sector is trading in the green. Let’s see who’s making big moves today.

    By Rajiv Nanjapla
  • uploads///marijuana
    Cannabis

    Marijuana in Hawaii: Is Further Legalization Likely?

    We’ve previously discussed the varying degrees of marijuana legalization in a variety of US states. Now, let’s talk about the laws in Hawaii.

    By Sushree Mohanty
  • uploads///cresco_
    Cannabis

    Cresco Labs: Analysts’ Ratings Post Q3 Earnings

    Cresco Labs (CRLBF) (CL) reported its third-quarter earnings results after markets closed on November 26. Its stock has since fallen.

    By Rajiv Nanjapla
  • uploads///FDA
    Cannabis

    Analysts Believe the FDA Will Get Tough on CBD

    Earlier this week, the FDA announced that it couldn’t conclude CBD was safe. It warned the public of various risks linked to CBD usage.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Cannabis Is Up Today: The Latest from CGC and Its Peers

    The cannabis sector is in the green today. At 12:58 PM ET, the ETFMG Alternative Harvest ETF and Horizons Marijuana Life Sciences Index ETF were up 0.8%.

    By Rajiv Nanjapla
  • uploads///cresco
    Cannabis

    Cresco Labs Missed Analysts’ Q3 Estimates

    Cresco Labs reported its third-quarter earnings on Tuesday after the market closed. The company missed analysts’ top-line and bottom-line estimates.

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    Why Cannabis Stocks Are Trending Down Today

    Today, the cannabis sector was trading in the red despite the broader US equity market trading in the green. Here’s what’s going on.

    By Rajiv Nanjapla
  • uploads///cresco labs
    Cannabis

    Can Cresco Lab’s Q3 Earnings Drive the Cannabis Sector?

    As of November 22, Cresco Labs was trading at 7.65 Canadian dollars, which implies a fall of 30% since its second-quarter earnings on August 21.

    By Rajiv Nanjapla
  • uploads///cresco
    Cannabis

    Cresco Labs’ Q3 Results Are Coming Up: What to Know

    US-based vertically-integrated cannabis player Cresco Labs is set to report its fiscal 2019 third-quarter results on November 26.

    By Margaret Patrick
  • uploads///charlottes web
    Cannabis

    Charlotte’s Web: Analysts Cut Targets after Weak Q3

    Charlotte’s Web Holdings reported its fiscal 2019 third-quarter earnings results on November 13. Its revenue came in at $25.1 million.

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    Charlotte’s Web: Q3 Earnings Missed Analysts’ Estimates

    Today, Charlotte’s Web Holdings (CWEB) (CWBHF) reported its third-quarter earnings. The company missed analysts’ revenue and EPS estimates.

    By Rajiv Nanjapla
  • Cannabis

    Cresco Labs Kicks Off Its Incubator Program in Illinois

    Cresco Labs launched its incubator program in Illinois on November 6. This program is part of Cresco’s Social Equity and Educational Development initiative.

    By Nivedha Elango
  • uploads///CB
    Cannabis

    Charlotte’s Web: Top Four Things to Know about the Stock

    Last month, Charlotte’s Web announced that it would partner with Nielsen to guide US retail companies on the growth of the CBD (cannabidiol) space.

    By Rajiv Nanjapla
  • uploads///MedMen_
    Cannabis

    MedMen: Stock Falls over 20% after Q4 2019 Earnings

    MedMen Enterprises (MMEN) (MMNFF) reported its fourth-quarter earnings that ended on June 30. The company reported revenues of $41.97 million.

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    Cannabis Sector in the Green despite Subdued Market

    While the US markets are subdued today, with the S&P 500 and Dow Jones both down, the cannabis sector is in the green. Here’s why.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    Cannabis Stocks Rise: CURLF, IIPR, ACB, WEED

    After closing in the red yesterday, the US equity market was trading marginally higher today. The cannabis sector is also up—and here’s why.

    By Rajiv Nanjapla
  • uploads///Cresco Labs
    Cannabis

    Cresco Labs Stock Rises on Dispensary Approval

    Yesterday, Cresco Labs (CRLBF) (CL) announced it had received licenses for its five Illinois medical cannabis dispensaries to sell adult-use cannabis.

    By Rajiv Nanjapla
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.